Thank you to all those that participated in Giving Tuesday this past week! After a week full of giving, we raised over $203,000 for myeloma research – wow! Thank you, thank you for making this work possible. We are so close to our goal of $250,000! If we can raise that amount by December 31,[...]

  It’s Giving Tuesday! This year, we are donating 100% of Giving Tuesday proceeds to three cutting-edge myeloma research projects from our Myeloma Crowd Research Initiative (MCRI). Each project was carefully selected by our team and we believe each will have a lasting impact on myeloma research. Thank you to all those that have donated![...]

  The Myeloma Crowd Research Initiative (MCRI) is a new approach to funding cancer research; combining the skill and knowledge of leading myeloma specialists with the patient perspective and supportive patient social communities to select and fund promising research projects in myeloma. Our goal is to find and fund a cure for multiple myeloma.  One[...]

  The Myeloma Crowd Research Initiative (MCRI) taps into the power of crowdsourcing and crowdfunding to find and fund the best ideas, research and clinical applications leading to new myeloma treatments or potential cures. Currently, the MCRI is funding three research projects:  Dr. Chung, MD, PhD – Creating an Immune System Signature Dr. Rodriguez, MD[...]

  The Myeloma Crowd Research Initiative (MCRI) taps into the power of crowdsourcing and crowdfunding to find and fund the best ideas, research and clinical applications leading to new myeloma treatments or potential cures. Currently, the MCRI is funding three research projects:  Dr. Chung, MD, PhD – Creating an Immune System Signature Dr. Rodriguez, MD[...]

  The Myeloma Crowd Research Initiative (MCRI) taps into the power of crowdsourcing and crowdfunding to find and fund the best ideas, research and clinical applications leading to new myeloma treatments or potential cures. Currently, the MCRI is funding three research projects:  Dr. Chung, MD, PhD – Creating an Immune System Signature Dr. Rodriguez, MD[...]

David Chung, MD, PhD Memorial Sloan Kettering Cancer Center Interview Date: November 19, 2018 Summary Why do some multiple myeloma patients relapse early after stem cell transplant while others stay in remission for many years? The patient’s immune system may be a key factor.   David Chung, MD, PhD of Memorial Sloan Kettering Cancer Center was[...]

  The first Myeloma Crowd Research Initiative (MCRI) successfully raised $500,000 for two immunotherapy research projects for high-risk myeloma (CAR T and T cell treatments). Now, the MCRI will fund research to match the right treatment with the right patient at the right time.  A small fraction of multiple myeloma patients may already be cured[...]

Monday, November 19, 2018 @ 10 am Pacific, 11 am Mountain, Noon Central, 1 pm Eastern Call In by Phone to Listen Live: (347) 637-2631 or Listen Live Via Computer Why do some multiple myeloma patients relapse early after stem cell transplant while others stay in remission for many years? The patient’s immune system may be[...]

In 2015 the Myeloma Crowd had a hypothesis: If patients collaborated with myeloma experts, we could accelerate a cure. Our dream has become a reality with the success of the first Myeloma Crowd Research Initiative (MCRI) campaign. Our recent announcement was shared here. The MCRI is the first patient-led crowdsourcing and crowdfunding initiative for multiple myeloma[...]